cevimeline hydrochloride

Generic: cevimeline hydrochloride

Labeler: bryant ranch prepack
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name cevimeline hydrochloride
Generic Name cevimeline hydrochloride
Labeler bryant ranch prepack
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

cevimeline hydrochloride 30 mg/1

Manufacturer
Bryant Ranch Prepack

Identifiers & Regulatory

Product NDC 71335-2264
Product ID 71335-2264_ea0ecfd4-85b2-47c8-8113-755d28555607
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091591
Listing Expiration 2026-12-31
Marketing Start 2013-07-08

Pharmacologic Class

Classes
cholinergic muscarinic agonists [moa] cholinergic receptor agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 713352264
Hyphenated Format 71335-2264

Supplemental Identifiers

RxCUI
309140
UNII
P81Q6V85NP

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name cevimeline hydrochloride (source: ndc)
Generic Name cevimeline hydrochloride (source: ndc)
Application Number ANDA091591 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 30 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (71335-2264-1)
  • 60 CAPSULE in 1 BOTTLE (71335-2264-2)
  • 90 CAPSULE in 1 BOTTLE (71335-2264-3)
source: ndc

Packages (3)

Ingredients (1)

cevimeline hydrochloride (30 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ea0ecfd4-85b2-47c8-8113-755d28555607", "openfda": {"unii": ["P81Q6V85NP"], "rxcui": ["309140"], "spl_set_id": ["fe30c870-a060-4a5b-ae61-6a9933854419"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (71335-2264-1)", "package_ndc": "71335-2264-1", "marketing_start_date": "20231027"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (71335-2264-2)", "package_ndc": "71335-2264-2", "marketing_start_date": "20231027"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71335-2264-3)", "package_ndc": "71335-2264-3", "marketing_start_date": "20231027"}], "brand_name": "Cevimeline Hydrochloride", "product_id": "71335-2264_ea0ecfd4-85b2-47c8-8113-755d28555607", "dosage_form": "CAPSULE", "pharm_class": ["Cholinergic Muscarinic Agonists [MoA]", "Cholinergic Receptor Agonist [EPC]"], "product_ndc": "71335-2264", "generic_name": "Cevimeline Hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cevimeline Hydrochloride", "active_ingredients": [{"name": "CEVIMELINE HYDROCHLORIDE", "strength": "30 mg/1"}], "application_number": "ANDA091591", "marketing_category": "ANDA", "marketing_start_date": "20130708", "listing_expiration_date": "20261231"}